Ing Groep Nv Intra Cellular Therapies, Inc. Transaction History
Ing Groep Nv
- $17.7 Billion
- Q3 2025
Shares
2 transactions
Others Institutions Holding ITCI
# of Institutions
44Shares Held
11.4MCall Options Held
600Put Options Held
0-
Black Rock Inc. New York, NY6.32MShares$834 Million0.01% of portfolio
-
Pictet Asset Management Sa Geneva 73, V81.67MShares$220 Million0.13% of portfolio
-
Eagle Asset Management Inc St Petersburg, FL625KShares$82.4 Million0.27% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL519KShares$68.5 Million0.01% of portfolio
-
Magnetar Financial LLC Evanston, IL436KShares$57.5 Million2.12% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $12.4B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...